Company Profile
Jinyu Bio-technology Co., Ltd. manufacturing and sales of veterinary biological drugs in China. Its operations are structured into three segments, such as veterinary biological products, veterinary chemical drugs, and traditional Chinese veterinary medicines.
The company offers various pig vaccines, including combined porcine circovirus type 2 and mycoplasma pneumoniae, classical swine fever, combined transmissible gastroenteritis and porcine epidemic diarrhea, swine influenza bivalent, porcine reproductive and respiratory syndrome, pseudorabies thermo-stable, porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 baculovirus vector, combined transmissible gastroenteritis and porcine epidemic diarrhea, swine foot and mouth disease bivalent, porcine parvovirus, pseudorabies, haemophilus parasuis trivalent, and porcine circovirus type 2 vaccines, as well as ruminant vaccines, such as foot and mouth disease trivalent, bovine pasteurella multocida, combined bovine viral diarrhea disease and infectious bovine rhinotracheitis, brucella gene deletion, goat pox, brucellosi, brucellosis, foot and mouth disease bivalent and type O, clostridium chauvoei, lumpy skin disease, combined ovine infectious necrotic hepatitis and braxy, and caprine infectious pleuropneumonia, as well as combined ovine braxy, struck, lamb dysentery, enterotoxaemia, and black disease and clostridium botulinum toxonosis vaccines.
Additionally, it offers avian vaccines. Its portfolio also includes rabies vaccines, and PCR and Elisa diagnostic kits. It also is involved in manufacturing and sales of veterinary chemical preparations, chemical reagents and auxiliary agents, biological drug preparations, and advanced medical equipment and instruments.
Its portfolio also includes biotechnology development, transfer, and consulting services, import and export of goods and technology, and provision of property management services. Founded in 1992, the company is headquartered in Hohhot, China.